Epidemiology of diabetic retinopathy

Epidemiology is the study of factors that determine the occurrence and distribution of disease in a population. In studying the epidemiology of diabetic retinopathy (DR), the literature is large and can be difficult for the clinician to mentally organize. To help in this regard, we note that reports generally display information in grids that are multidimensional.

[1]  D. Simon,et al.  Management of diabetic patients by general practitioners in France 1997: an epidemiological study. , 2000, Diabetes & metabolism.

[2]  R. Klein,et al.  The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. , 1997, Transactions of the American Ophthalmological Society.

[3]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.

[4]  M. Roy,et al.  Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. , 2006, Archives of ophthalmology.

[5]  Shan C. Lin,et al.  Prevalence and Risk Factors of Diabetic Retinopathy in a Multi-Racial Underserved Population , 2008, Ophthalmic epidemiology.

[6]  D. Belsky,et al.  Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005. , 2008, Archives of ophthalmology.

[7]  J. Shaw,et al.  Longitudinal Association of Glucose Metabolism With Retinopathy , 2008, Diabetes Care.

[8]  S. Harding,et al.  Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[9]  R. Klein,et al.  Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. , 2008, Archives of ophthalmology.

[10]  J. Caro,et al.  Lifetime costs of complications resulting from type 2 diabetes in the U.S. , 2002, Diabetes care.

[11]  J. J. Wang,et al.  Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study , 2007, Eye.

[12]  G. Giani,et al.  Incidence of blindness in southern Germany between 1990 and 1998 , 2001, Diabetologia.

[13]  Tin Aung,et al.  Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. , 2008, Ophthalmology.

[14]  G. Bresnick,et al.  DIABETIC MACULAR EDEMA: A REVIEW , 1986 .

[15]  J. J. Wang,et al.  Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. , 1998, Ophthalmology.

[16]  C. Propper,et al.  Socio‐economic inequalities in diabetes complications, control, attitudes and health service use: a cross‐sectional study , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[17]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. , 1989, Ophthalmology.

[18]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[19]  Fatma Al-Maskari,et al.  Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey , 2007, BMC ophthalmology.

[20]  Beverley Balkau,et al.  The prevalence of and factors associated with diabetic retinopathy in the Australian population. , 2003, Diabetes care.

[21]  Michael Happich,et al.  The economic burden of diabetic retinopathy in Germany in 2002 , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[22]  M. Roy.  Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: II. Risk factors. , 2000, Archives of ophthalmology.

[23]  S. Resnikoff,et al.  Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.

[24]  V. Mohan,et al.  Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. , 2005, Investigative ophthalmology & visual science.

[25]  T. Skrivarhaug,et al.  Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study , 2006, Diabetologia.

[26]  Rachel Leach,et al.  Rethinking the “Diseases of Affluence” Paradigm: Global Patterns of Nutritional Risks in Relation to Economic Development , 2005, PLoS medicine.

[27]  F. Ferris,et al.  Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. , 1998, Investigative ophthalmology & visual science.

[28]  R. Varma.  From a population to patients: the Wisconsin epidemiologic study of diabetic retinopathy. , 2008, Ophthalmology (Rochester, Minn.).

[29]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[30]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. , 1984, Ophthalmology.

[31]  J. Jonas,et al.  Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006 , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  J C Javitt,et al.  Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. , 1989, Ophthalmology.

[33]  L. Rand,et al.  Risk of Proliferative Diabetic Retinopathy in Juvenile-Onset Type I Diabetes: A 40-yr Follow-up Study , 1986, Diabetes Care.

[34]  R. Klein,et al.  The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. , 2002, Ophthalmology.

[35]  M. Saad,et al.  Prevalence and risk factors for diabetic retinopathy among Omani diabetics , 1998, The British journal of ophthalmology.

[36]  Lloyd Paul Aiello,et al.  Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. , 2007, Archives of ophthalmology.

[37]  K. Summers,et al.  Diabetic retinopathy: contemporary prevalence in a well-controlled population. , 2003, Diabetes care.

[38]  F. Bandello,et al.  Diabetic retinopathy , 2002, Diabetologia.

[39]  M. Uusitupa,et al.  Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects. 10-year follow-up from the diagnosis. , 2001, Journal of diabetes and its complications.

[40]  R. Klein,et al.  Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials , 2008, The Lancet.

[41]  H. Taylor,et al.  Five‐year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project , 2003, Clinical & experimental ophthalmology.

[42]  Stephen J. Aldington,et al.  UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.

[43]  R. Klein,et al.  Ten-year incidence of visual loss in a diabetic population. , 1994, Ophthalmology.

[44]  Rajeev Gupta,et al.  Global diabetes landscape—type 2 diabetes mellitus in South Asia: Epidemiology, risk factors, and control , 2008 .

[45]  R. Hamman,et al.  Prevalence and Risk Factors of Diabetic Retinopathy in Non-Hispanic Whites and Hispanics With NIDDM: San Luis Valley Diabetes Study , 1989, Diabetes.

[46]  Simon P Harding,et al.  Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study , 2003, The Lancet.

[47]  F Plum,et al.  Incidence of Blindness in Relation to Diabetes: A population-based study , 1997, Diabetes Care.

[48]  Epidemiology of diabetes. , 2002, Advanced drug delivery reviews.

[49]  M. Amini,et al.  Prevalence of macro- and microvascular complications among patients with type 2 diabetes in Iran: a systematic review. , 2009, Diabetes research and clinical practice.

[50]  W. Herman,et al.  The Effects of Treatment on the Direct Costs of Diabetes , 1998, Diabetes Care.

[51]  Joseph Cavanaugh,et al.  Probability and Random Variables , 1999, Mathematical Modelling.

[52]  T. Bek,et al.  The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. , 2004, Acta ophthalmologica Scandinavica.

[53]  R. Klein,et al.  Visual impairment in diabetes. , 1984, Ophthalmology.

[54]  The National Screening Committee review of diabetic retinopathy screening. , 2001 .

[55]  A. Patz,et al.  Clinically significant macular edema in type I diabetes. Incidence and risk factors. , 1995, Ophthalmology.

[56]  J. Skurnick,et al.  Six-year incidence of visual loss in african americans with type 1 diabetes mellitus: the New Jersey 725. , 2007, Archives of ophthalmology.

[57]  M. Falk,et al.  Cost-benefit analysis of diabetic eye disease. , 1996, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[58]  P. Rossing.  The changing epidemiology of diabetic microangiopathy in type 1 diabetes , 2005, Diabetologia.

[59]  R. J. Hayes,et al.  United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy , 1998, Annals of Internal Medicine.

[60]  M. C. Leske,et al.  Diabetic retinopathy in a black population: the Barbados Eye Study. , 1999, Ophthalmology.

[61]  Lloyd Paul Aiello,et al.  Preventive Eye Care in People With Diabetes Is Cost-Saving to the Federal Government: Implications for health-care reform , 1994, Diabetes Care.

[62]  K. Wang,et al.  [Study on the epidemiological characteristics of diabetes mellitus and IGT in China]. , 1998, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[63]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[64]  R. Klein,et al.  Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. , 2004, Ophthalmology.

[65]  R. Sarin.  Criteria for deciding cost-effectiveness for expensive new anti-cancer agents. , 2008, Journal of cancer research and therapeutics.

[66]  R. Klein,et al.  Is the Risk of Diabetic Retinopathy Greater in Non-Hispanic Blacks and Mexican Americans Than in Non-Hispanic Whites With Type 2 Diabetes?: A U.S. population study , 1998, Diabetes Care.

[67]  J. Forrester,et al.  Epidemiology of diabetic retinopathy and macular oedema: a systematic review , 2004, Eye.

[68]  X. Mundet,et al.  Prevalence and incidence of chronic complications and mortality in a cohort of type 2 diabetic patients in Spain. , 2008, Primary care diabetes.

[69]  D. Friedman,et al.  Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. , 2009, Ophthalmology.

[70]  Epidemiological analysis of patients with Type 2 diabetes in France. , 2000, Journal of diabetes and its complications.

[71]  D. Simmons,et al.  Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry diabetes study. , 1989, BMJ.

[72]  B. Munoz,et al.  Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes. , 2008, Archives of ophthalmology.

[73]  Giel Nijpels,et al.  Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. , 2003, Archives of ophthalmology.

[74]  R. Klein,et al.  The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. , 1994, Archives of ophthalmology.

[75]  C. Creuzot-Garcher,et al.  Dépistage de larétinopathie diabétique en Bourgogne par un rétinographe non mydriatique itinérant , 2007 .

[76]  H. Taylor,et al.  Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project , 2000, The British journal of ophthalmology.

[77]  M. C. Leske,et al.  Incidence of diabetic retinopathy in the Barbados Eye Studies. , 2003, Ophthalmology.

[78]  A. Sinclair,et al.  Prevalence of diabetes in care home residents. , 2001, Diabetes care.

[79]  J. Saaddine,et al.  Diabetes mellitus and visual impairment: national health and nutrition examination survey, 1999-2004. , 2008, Archives of ophthalmology.

[80]  R. Klein,et al.  The economic burden of major adult visual disorders in the United States. , 2006, Archives of ophthalmology.

[81]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[82]  K. Hsiao,et al.  A Population Survey on the Prevalence of Diabetes in Kin-Hu, Kinmen , 1994, Diabetes Care.

[83]  C. Delcourt,et al.  Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: a multicenter study. CODIAB-INSERM-ZENECA Pharma Study Group. , 1998, Journal of diabetes and its complications.

[84]  D. Reda,et al.  Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial. , 2005, Diabetes care.

[85]  C. Chen,et al.  Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. , 1992, American journal of ophthalmology.

[86]  N. Nguyen,et al.  Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. , 2008, Journal of the American College of Surgeons.

[87]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[88]  J. J. Wang,et al.  Five-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye Study , 2006, Eye.

[89]  Ronald Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. , 2009, Ophthalmology.

[90]  Andrew F. Smith,et al.  The economic impact of ophthalmic services for persons with diabetes in the Canadian Province of Nova Scotia: 1993–1996 , 2001, Ophthalmic epidemiology.

[91]  A. Girach,et al.  Diagnosed diabetic retinopathy in France, Italy, Spain, and the United Kingdom. , 2007, Primary care diabetes.

[92]  G. Dardanoni,et al.  Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects: The Casteldaccia Eye Study , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[93]  R. Klein,et al.  Is there an ethnic difference in the effect of risk factors for diabetic retinopathy? , 1993, Annals of epidemiology.

[94]  R. Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. , 1995, Ophthalmology.

[95]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[96]  Ronald Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. , 2008, Ophthalmology.

[97]  T. Wong,et al.  Management of diabetic retinopathy: a systematic review. , 2007, JAMA.

[98]  S. Twigg,et al.  Timing Is Everything: Age of Onset Influences Long-Term Retinopathy Risk in Type 2 Diabetes, Independent of Traditional Risk Factors , 2008, Diabetes Care.

[99]  Martin Salm,et al.  Trends in cost of major eye diseases to Medicare, 1991 to 2000. , 2006, American journal of ophthalmology.

[100]  R. Klein,et al.  Diabetic retinopathy in a multi-ethnic cohort in the United States. , 2006, American journal of ophthalmology.

[101]  R. Klein,et al.  The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. , 1992, Ophthalmology.

[102]  Ronald Klein,et al.  The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. , 2004, Archives of ophthalmology.

[103]  M. Stern,et al.  Diabetic retinopathy in Mexico. Prevalence and clinical characteristics. , 1994, Archives of medical research.

[104]  S. Harris,et al.  Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review. , 2008, Diabetes research and clinical practice.

[105]  Rajiv Raman,et al.  Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. , 2009, Ophthalmology.

[106]  H. Parving,et al.  Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. , 2003, Diabetes care.

[107]  Jonathan Javitt,et al.  Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy , 1996, Annals of Internal Medicine.

[108]  L. Kuller,et al.  Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II , 1990, Diabetes.

[109]  J. Jacob,et al.  Longitudinal study of a cohort of people with diabetes screened by the Exeter Diabetic Retinopathy Screening Programme , 2002, Eye.

[110]  G. Reach,et al.  Association among individual deprivation, glycemic control, and diabetes complications: the EPICES score. , 2005, Diabetes care.

[111]  P. Mitchell,et al.  Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: Population-based survey findings. , 2006, Diabetes research and clinical practice.

[112]  M. C. Leske,et al.  Nine-year incidence of diabetic retinopathy in the Barbados Eye Studies. , 2006, Archives of ophthalmology.